欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称HumaSPECT
适用类别Human
治疗领域Ultrasonography;Colorectal Neoplasms;Tomography, X-Ray Computed
通用名/非专利名称votumumab
活性成分votumumab
产品号EMEA/H/C/000145
患者安全信息No
许可状态Withdrawn
ATC编码V09IX
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期1998/09/25
上市许可开发者/申请人/持有人KS Biomedix Limited
人用药物治疗学分组Diagnostic radiopharmaceuticals
兽用药物治疗学分组
欧盟委员会决定日期2003/09/24
修订号
治疗适应症After reconstitution with sodium pertechnetate [99mTc] solution, HumaSPECT [99mTc] is indicated in patients with histologically proven carcinoma of the colon or rectum for imaging of recurrence and/or metastases. HumaSPECT [99mTc] is employed, in the above mentioned patients, as an adjunct to standard non invasive imaging techniques, such as ultrasonography or CT scan, in the following situations.• Patients with evidence of recurrence and/or metastatic carcinoma of the colon or rectum, who are undergoing an evaluation for extent of disease, such as prior to surgical resection and/or other therapy.• Patients with suspected recurrence and/or metastatic carcinoma of the colon or rectum in association with rising levels of carcinoembryonic antigen (CEA).
适用物种
兽用药物ATC编码
首次发布日期2003/09/24
最后更新日期2004/02/23
产品说明书
公共评估报告https://www.ema.europa.eu/en/medicines/human/EPAR/humaspect
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase